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Crystal structure of the chemotaxis receptor methyltransferase
CheR suggests a conserved structural motif for binding
S-adenosylmethionine
Snezana Djordjevic and Ann M Stock*
Background: Flagellated bacteria swim towards favorable chemicals and away
from deleterious ones. The sensing of chemoeffector gradients involves
chemotaxis receptors, transmembrane proteins that detect stimuli through their
periplasmic domains and transduce signals via their cytoplasmic domains to the
downstream signaling components. Signaling outputs from chemotaxis receptors
are influenced both by the binding of the chemoeffector ligand to the periplasmic
domain and by methylation of specific glutamate residues on the cytoplasmic
domain of the receptor. Methylation is catalyzed by CheR, an
S-adenosylmethionine-dependent methyltransferase. CheR forms a tight complex
with the receptor by binding a region of the receptors that is distinct from the
methylation site. CheR belongs to a broad class of enzymes involved in the
methylation of a variety of substrates. Until now, no structure from the class of
protein methyltransferases has been characterized.
Results: The structure of the Salmonella typhimurium chemotaxis receptor
methyltransferase CheR bound to S-adenosylhomocysteine, a product and
inhibitor of the methylation reaction, has been determined at 2.0 Å resolution. The
structure reveals CheR to be a two-domain protein, with a smaller N-terminal
helical domain linked through a single polypeptide connection to a larger
C-terminal a/b domain. The C-terminal domain has the characteristics of a
nucleotide-binding fold, with an insertion of a small antiparallel b sheet
subdomain. The S-adenosylhomocysteine-binding site is formed mainly by the
large domain, with contributions from residues within the N-terminal domain and
the linker region.
Conclusions: The CheR structure shares some structural similarities with small
molecule DNA and RNA methyltransferases, despite a lack of sequence similarity
among them. In particular, there is significant structural preservation of the
S-adenosylmethionine-binding clefts; the specific length and conformation of a
loop in the a/b domain seems to be required for S-adenosylmethionine binding
within these enzymes. Unique structural features of CheR, such as the
b subdomain, are probably necessary for CheR’s specific interaction with its
substrates, the bacterial chemotaxis receptors.
Introduction
The methyltransferases are a large and diverse class of
enzymes that catalyze the transfer of methyl groups from
S-adenosylmethionine (AdoMet) to a wide range of sub-
strates, including small molecules, nucleic acids and pro-
teins. Despite the use of a common cofactor, AdoMet, the
mechanism of methyl transfer is not conserved among
methyltransferases. This may be reflected in the lack of dis-
tinguishing sequence motifs that define the active sites of
methyltransferases, comparable to the consensus sequences
characteristic of the nucleotide-binding sites of kinases and
dehydrogenases. And although AdoMet is the second most
commonly used cofactor after ATP, there are relatively few
structural descriptions of AdoMet-binding sites. 
The three-dimensional structures of several DNA methyl-
transferases [1–3], an RNA methyltransferase [4] and 
two small molecule methyltransferases [5,6] have been
determined, but structural information regarding protein
methyltransferases is lacking. Protein methyltransferases
are diverse both with respect to the target amino acid
modified by methylation and the proposed role of the
modification [7]. Some protein methylations are irre-
versible and are assumed to have a structural role, such
as the methylation of a-amino groups of a variety of N-ter-
minal amino acids or the N-methylations of histidine,
arginine and lysine sidechains. Methylation at protein car-
boxyl groups, however, is reversible and appears to func-
tion more dynamically. Methylation of aspartyl sidechains
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is proposed to be involved in repair of damaged pro-
teins [8,9], and methylations of the C-terminal a-carboxyl
groups of eukaryotic proteins [10,11] and of the glutamyl
sidechain carboxyl groups in bacterial receptors [12,13] are
involved in signal transduction.
Bacterial chemotaxis transmembrane receptors are reversibly
modified by methylation of four to five glutamate residues
within their cytoplasmic domains (reviewed in [14,15]).
The methylation–demethylation reactions are catalyzed 
by CheR, an AdoMet-dependent protein methyltrans-
ferase, and CheB, a methylesterase/amidase. Methylation of
the chemoreceptors counterbalances the effects of ligand
binding, and contributes to the phenomenon of adaptation
by resetting the signaling activity of the receptors despite
the continued presence of stimulus. Methylation of the
receptors is highly regulated by multiple mechanisms. The
regulation of enzyme activity occurs primarily through
control of the methylesterase CheB, a response regulator
protein that is activated by a two-component phosphotrans-
fer pathway [16,17]. Additionally, both methylating and
demethylating reactions are influenced by the specific con-
formation of the receptors which presumably affects acces-
sibility of the glutamate residues [18–20]. Each specific
glutamate residue is methylated at a characteristic rate,
which correlates with the magnitude of the effect on chemo-
taxis of mutation of the specific residue [21,22]. The methyl-
transferase CheR binds to a five amino acid tail at the
C termini of some chemoreceptors; this tail is distant in
primary sequence from CheR’s sites of methylation [23].
Data suggests that from this tethered position, the methyl-
transferase methylates other chemoreceptor dimers through
inter-dimer interactions.
The structure of the Salmonella typhimurium chemotaxis
receptor methyltransferase CheR bound to S-adeno-
sylhomocysteine (AdoHcy), a product and inhibitor of 
the methylation reaction, has been determined at 2.0 Å
resolution. This is the first report of the structure of 
a protein methyltransferase. Unlike catechol-O-methyl-
transferase and cytosine-DNA methyltransferases, the
active site of CheR involves neither metal ions nor a
methylcysteinyl intermediate in catalysis. In this respect,
CheR is similar to the adenine-DNA methyltransferase
and RNA methyltransferase vaccinia protein VP39.
Although there are specific differences in topologies, pre-
sumably due to the nature of substrates for each enzyme,
the structure of CheR confirms that methyltransferases
from all four substrate groups (proteins, DNA, RNA and
small molecules) share some structural features. Struc-
tural analysis of the four classes of enzymes indicates
that the AdoMet-binding site is characterized by the spe-
cific conformation of a b1/aA loop within the a/b domain,
with additional interactions contributed by residues of a
linker to an additional domain that is commonly involved
in substrate recognition. These features are specific to
methyltransferases and distinct from cofactor-binding
sites of other nucleotide-binding proteins. In addition to
the interest in CheR as an AdoMet-dependent protein
methyltransferase, its structure provides a foundation for
beginning to explore the complex interactions between a
chemotaxis receptor modification enzyme and its multi-
ple substrates.
Results and discussion
Structure determination
The structure of S. typhimurium CheR in a complex with
AdoHcy was determined at 2.0Å resolution by multiple
isomorphous replacement (MIR). The crystals belong to
the monoclinic space group P21. Diffraction data for native
and several heavy-atom derivatized crystals were obtained
as summarized in Table 1. A native data set for a crystal
equilibrated at pH7.0 was also collected. These data
merged well with data from the original native crystal
grown at pH5.6 (Rmerge =4.9%), thus a more suitable
neutral pH was chosen for preparation of the derivatives.
An electron-density map that was calculated with density
modified MIR phases is shown in Figure 1.
The atomic model of CheR was refined by using a combi-
nation of X-PLOR and ARP procedures (see Materials
and methods for details). The final model has good geom-
etry with only one residue, Ser125, outside of the allowed
regions of a Ramachandran plot. Ser125 is located in the
core of the molecule and is involved in formation of the
cofactor-binding site. The unusual backbone conforma-
tion of this residue is perhaps unremarkable, because
active-site residues commonly acquire unusual phi and
psi angles. 
The final model contains 2224 non-hydrogen protein
atoms corresponding to residues 11 to 284, 26 non-hydro-
gen atoms belonging to AdoHcy and 110 solvent mol-
ecules. The crystallographic R factor for this model is
19.6% for 18 035 reflections between 8.0 and 2.0Å resolu-
tion, and the free R factor, calculated with 5% of the data,
is 27.8%. The root mean squared (rms) deviations from
ideal geometry are 0.014Å for bond lengths and 1.7° for
bond angles. A summary of the overall quality of the
model is presented in Table 2.
The N-terminal ten residues of CheR are not visible in
electron-density maps. An N-terminal sequence analysis
of the CheR protein, obtained by dissolving the native
crystals, indicated that approximately 90% of the protein
molecules started at residue Thr2 (indicating removal of
the N-terminal Met), with a minor portion of the protein
molecules starting at Gln15. These data are in accordance
with an apparent disorder of the N-terminal end of the
polypeptide chain. Additionally, four amino acids at the
C terminus of CheR, residues 285–288, are not observed
in electron-density maps. 
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Protein architecture
CheR is a two-domain mixed a/b protein. The a-carbon
tracing, ribbon diagram and CPK model of CheR are shown
in Figure 2. A topology diagram of CheR is shown in
Figure 3. The smaller, N-terminal domain of CheR con-
tains residues 11–90. This domain consists of four perpen-
dicularly packed helices (a1–a4) and an extended terminus
formed by residues 11–20, which are oriented away from
the domain without interactions with the rest of the mol-
ecule. In the crystal, residues 11–20 are packed between
two crystallographic symmetry-related molecules, forming
few hydrogen bonds and exhibiting high temperature
factors (~40Å2). It is very likely that the conformation of
this region is influenced by crystal packing. It is conceiv-
able that the N-terminal twenty residues acquire a different
conformation, when interacting with the chemotaxis recep-
tors or in the vicinity of the cytoplasmic membrane. Helix
a4 of the N-terminal domain is connected to helix a5 of the
C-terminal domain through an extended linker sequence
(residues 91–98). A relatively small (~ 440Å2) interface
between the two domains contains eight hydrogen-bond
interactions at the outer rim of the interface, with five
hydrophobic residues grouped at the center. Association
between the small N-terminal domain, the linker region
and the large C-terminal domain is apparent in the CPK
representation of the model (Fig. 2c).
The C-terminal domain is composed of residues 99–284.
The core of this domain consists of a mixed seven-stranded
b sheet that is flanked on both sides by a helices. The
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Table 1
Data collection and MIR phasing.
Compound Concentration Soaking Res* Com.† Rmerge‡ R factor§ No. of Phasing# Rcullis¶
(mM) time (days) (Å) (%) (%) (%) sites power (%)
native pH5.6 - 2.0 90 5.0 - - - -
native pH7.0 - - 2.0 93 4.9 - - - -
C2H5C1Hg 1 3 2.7 76 6.0 23.1 2 2.8 51
C2H5C1Hg II 1 3 2.7 85 4.3 24.2 2 2.8 51
Baker’s 1 3 2.7 87 5.3 23.3 3 1.4 73
Baker’s II 1 3 2.7 89 4.8 34.3 2 1.4 81
DMA 1 3 3.0 78 7.6 42.3 3 1.5 72
K2PtC14 0.5 3 hrs 3.0 85 5.7 34.7 3 1.2 83
*Resolution limit of phasing. †Completeness of data set. ‡Rmerge = ΣΣ | Ih,i – < Ih> | / ΣΣ< Ih >. §R factor = Σ | |IPH| –| IP | | / Σ |IP|. #Rms amplitude of the
heavy atom F / residual lack of closure. ¶Rcullis = Σ | |FPH – FP | – | FH | | / Σ | FH |.
Figure 1
Representative portion of an experimental
electron-density map. A stereo image of a
region of the final CheR model (black line) is
shown superimposed with an MIR/DM
electron-density map calculated to 2.7 Å and
contoured at 1σ. The figure shows the
electron density associated with residues
129—153.
W148          
I133
F151
D139
E129
S153
W148          
I133
F151
D139
E129
S153
overall topology of the C-terminal a/b domain is common to
other previously characterized methyltransferases (Fig. 3).
For consistency, in the topological comparison, b strands
and a helices are labeled according to the nomenclature
previously used for the description of methyltransferases
[24,25]. The basic topology represents a variation of a Ross-
mann-type a/b fold. This was also confirmed by the results
of a structural similarity search carried out using DALI [26],
which in addition to methyltransferases, identified forty
other structures with similarity greater than Z=3.1s (Z is
the standard deviations above the mean). These molecules
were mostly NAD- and FAD-dependent dehydrogenases
and reductases. The methylesterase domain of CheB [27]
also shares a structural similarity to CheR (Z=3.3s), even
though this enzyme does not utilize a nucleotide cofactor.
The structural similarity between CheR and CheB might
reflect a common evolutionary origin or a requirement for a
common scaffold that enables them to react with the same
substrates, the chemotaxis receptors.
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Table 2
Refinement statistics.
Number of atoms 2360
Resolution (Å) 2.0
Number of reflections 18 035
Number of water molecules 110
R factor (%) 19.6
Rfree (%)* 27.8
Rms bond length (Å) 0.014
Rms bond angle (°) 1.7
Average thermal factors
Mainchain (Å2) 21.0
Sidechain (Å2) 25.1
*Rfree was calculated from 5% of reflection data.
Figure 2
The three-dimensional fold of CheR. (a) A
stereo image of the Ca chain of CheR with
residue numbers indicated. (b) A ribbon
diagram (RIBBONS; [56]) of CheR, showing
a helices in green, b strands in yellow and 310
helical turns in blue. The AdoHcy molecule
bound to CheR is shown in solid spheres.
Colors are gray for carbon, blue for nitrogen,
red for oxygen and yellow for sulfur atoms.
(c) A CPK model of CheR, including all
atoms. Green spheres indicate residues of the
a/b domain and gold spheres indicate
residues of the N-terminal helical domain and
the linker region. Atoms of the AdoHcy
molecule are colored the same as in (b). From
this orientation, only gray carbon atoms of
AdoHcy are visible. In these figures, the
orientations of the model are approximately
the same. Figures (a) and (c) were prepared
using TURBO.
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A novel feature of CheR’s C-terminal domain is the pres-
ence of a small subdomain composed of an a helix and a
short antiparallel three-stranded b sheet. This subdomain
(residues 166–199) is inserted after aB, at one edge of the
b sheet. The subdomain stands almost independently,
away from the structure, with only one region involved in
interactions with the rest of the a/b domain. Approxi-
mately 420Å2 of the molecular surface of the a/b domain
is buried in the subdomain. At the interface, six hydro-
phobic residues from the subdomain contribute to the
hydrophobic interactions; two of these are tyrosines that
also form two out of a total of four hydrogen bonds.
The binding mode of the adenine portion of AdoMet
resembles that of NAD in NAD-dependent enzymes,
such as alcohol dehydrogenase [29]. The adenine ring 
is positioned within a hydrophobic pocket sandwiched
between two relatively large aliphatic residues (Ile155 and
Val232 in the case of CheR), while an acidic residue
(Asp154) forms a hydrogen bond with the hydroxyl groups
of the ribose ring. In addition, an amino group from the
adenine ring forms a hydrogen bond with the backbone
carbonyl oxygen of Ala38, within the N-terminal helical
domain, and also with the sidechain carbonyl oxygen of
Asn212. The homocysteine portion of AdoHcy extends
away from the ribose, fitting into an elongated groove in
the CheR molecule formed by residues from both the
C-terminal domain and the linker region. The oxygen
atoms from the carboxyl and amino groups of the homo-
cysteine form hydrogen bonds either with sidechain
atoms pointing towards the binding cleft or with the sur-
rounding backbone atoms of CheR. All of the residues
that are engaged in hydrogen bonds to the homocysteine
are completely conserved among the CheR proteins from
a wide variety of bacterial species. The residues forming
the hydrophobic environment around the adenine ring,
although not completely conserved, are highly similar in
all of the CheR sequences. 
Because of the involvement of cysteine residues in the
catalysis of methyl transfer by cytosine-DNA methyl-
transferases, the two cysteine residues in S. typhimurium
CheR, Cys31 and Cys229, have been the focus of a
number of mutagenesis and biochemical studies [30]. 
Substitution of Cys31 with serine resulted in an 80%
decrease in methyltransferase activity. Furthermore, it
was shown that inactivation of wild-type or Cys229→
Ser-mutant CheR by sulfhydryl reagents could be pre-
vented by preincubation of the enzymes with AdoMet. In
another report, Cys31 was photolabeled with S-adenosyl-
L-[methyl-3H]methionine, suggesting that Cys31 was
located at, or near, the AdoMet-binding site [31]. 
Surprisingly, neither Cys31 nor Cys229 are part of the
active site. In the three-dimensional structure of CheR,
Cys31 resides within the N-terminal domain, ~15 Å away
from the AdoHcy-binding site. Thus, it appears that the
observed decrease in activity of the Cys31→Ser mutant
is a consequence of some effect other than direct partici-
pation of this residue in the catalytic reaction. We were
unable to obtain crystals of CheR in the absence of
cofactor, which may indicate a somewhat flexible nature
of the molecule, specifically with respect to the inter-
domain connection. In fact, due to the buried nature 
of the AdoHcy-binding site (Fig. 2c), significant move-
ment of the domains must occur to provide the cofactor
access to the binding cleft. Given that the N-terminal
domain and linker region also contribute to AdoHcy
binding, binding of cofactor may lock Cys31 into a less
solvent accessible position and thus protect it from
sulfhydryl reagents. In reverse, the Cys31Ser mutation
may disrupt inter-domain interactions and thus affect
AdoMet binding.
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Figure 3
Schematic topology diagram of CheR, catechol-O-methyltransferase
(COMT), HaeIII, HhaI and TaqI DNA methyltransferases, RNA
methyltransferase VP39 and the catalytic domain of CheB. Helices and
strands that are approximately perpendicular to the plane of the figure
are represented by circles and triangles, respectively, and the helices
that are close to being parallel to the plane of the figure are shown as
rods. Dashed lines denote the positions of additional domains. Helical
turns that are less than four residues long are not shown as helices in
the figure.
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Comparison of cofactor-binding sites in CheR and other
methyltransferases
Overall sequence similarity among methyltransferases that
methylate different types of substrates is very weak. Analy-
sis of amino acid sequences of a broad range of AdoMet-
dependent methyltransferases revealed only three short
regions with sequence similarity [32]. It was suggested that
the amino acids in these regions might have a common
function, such as the binding of AdoMet/ AdoHcy, or alter-
natively might be indicators of a common evolutionary
origin. More recently, a structure-guided analysis revealed
nine conserved sequence motifs specific to DNA amino-
methyltransferases [24]. Even though the sequential order
of these motifs varies in DNA amino-methyltransferases,
their sequence similarity is significant. On the basis of
structural and sequence comparisons, it has been proposed
that many, and possibly all, AdoMet-dependent methyl-
transferases have a common catalytic-domain structure
[33,25]. Recent publications have examined the primary
sequence composition of the AdoMet/AdoHcy-binding site
[4] and have addressed its relationship with the NADbind-
ing site of alcohol dehydrogenase [34]. Crystal structures
are now available for members of all four major classes of
methyltransferases: three DNA methyltransferases — HhaI
[35], TaqI [2] and HaeIII [3]; an RNA methyltransferase —
VP39[4]; two small molecule methyltransferases — catche-
chol-O-methyltransferase [5] and glycine methyltransferase
[6]; and a protein methyltransferase — CheR. In addition,
many more amino acid sequences for a variety of methyl-
transferases are also available, which enable us to address
the questions of cofactor binding, evolutionary origin and
possible identification of characteristic primary or tertiary
structure elements. 
We have superimposed all available methyltransferase
structures and have examined the AdoMet/AdoHcy-
binding sites in order to carry out a comprehensive and
detailed analysis. Table 3 summarizes the structural com-
parisons of the cofactor-binding sites by listing the residues
within a 4Å distance to the cofactor molecule. We included
only the DNA-bound structure of HhaI cytosine methyl-
transferase and not the DNA-free form. In the latter
structure, the AdoMet molecule exhibited an inverted ori-
entation within the binding cleft [1], which the authors
subsequently suggested was probably a non-physiological
phenomenon related to the crystal packing [35]. Addi-
tionally, glycine methyltransferase was excluded from our
analysis even though it exhibits a great deal of structural
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S-adenosylhomocysteine-binding site in CheR. (a) A stereo diagram
(MOLSCRIPT; [57]) of the AdoHcy-binding site. Only sidechain atoms
are included in the figure except for the residues that form hydrogen
bonds with AdoHcy through mainchain atoms. Hydrogen bonds are
represented by dashed lines. (b) A schematic view of the contacts
identified in the crystal structure of the CheR–AdoHcy complex.
Hydrogen bonds are drawn with dashed lines and covalent bonds are
shown as solid lines connecting the solid spheres that denote atoms.
Residues within the hydrophobic pocket that accommodates the
adenine portion of AdoHcy are represented by parallel curved lines.
Sulfur atoms are shown in green, other atom colors are the same as
Figure 2. 
similarity with other methyltransferases. AdoMet binds
very differently in this enzyme, primarily due to the multi-
meric nature of glycine methyltransferase and the presence
of an additional domain [6]. Glycine methyltransferase also
binds tetrahydrofolate and polycyclic aromatic hydrocarbon
molecules, indicating a much less AdoMet-specific binding
character. The active site of this enzyme presumably rep-
resents an entirely different class of cofactor-binding sites. 
The only residues common to all AdoMet-binding sites are
an aspartate or a glutamate, which forms hydrogen bonds to
the hydroxyl groups of the ribose and, with the exception
of VP39, an aspartate, glutamate or asparagine, which forms
hydrogen bonds to the amino group of the adenine. These
residues, however, are also found in alcohol dehydrogenase
and other enzymes that bind NAD, a cofactor with adenine
and ribose moieties identical to AdoMet/ AdoHcy. Inter-
estingly, in RNA methyltransferase VP39, there is also an
aspartate residue in a corresponding position. This aspar-
tate, however, points away from the AdoMet, and instead
the adenine amino group forms a hydrogen bond with the
carbonyl oxygen of the neighboring residue. Similarly 
to the adenine of NAD in NAD-dependent enzymes, 
the adenine ring of AdoMet/AdoHcy in all methyltrans-
ferases is situated within a hydrophobic pocket of variable
residues. There is also variability in the methyltransferase
residues that participate in hydrogen bonds with the car-
boxyl and amino groups of the methionine portion of
AdoMet/AdoHcy. 
Based on examination of the structures, it appears that the
size and shape of the AdoMet-binding clefts are very
similar in all methyltransferases, despite the apparent lack
of sequence identity. Importantly, in all of the methyl-
transferases, the binding cleft is formed mainly by residues
coming from the a/b domain, with some additional contri-
butions from residues within the linker region that con-
nects the a/b domain to an additional domain, which is
commonly involved in determining substrate specificity.
The loop connecting the first b strand in the a/b domain
to the following a helix is well characterized in NAD-
binding enzymes as it contains the conserved sequence
motif Gly–X–Gly–Gly, in which the last glycine is the first
residue of the a helix. In methyltransferases, the sequence
of this loop is much less conserved. The loop is two
residues longer compared to that of alcohol dehydroge-
nase, such that it greatly affects the position of the con-
necting a helix, and it directs the shape of the bed of the
AdoMet-binding cleft over which the methionine portion
of the cofactor is positioned. The sequences involved in
forming this loop are listed in Table 3. A common feature
of all methyltransferases is that the loop ends with a
glycine residue and in all but RNA methyltransferase
VP39, the third residue within the loop displays specific
phi/psi values (approximately phi =50 and psi=–130)
falling into a disallowed region of the Ramachandran plot,
regardless of the amino acid type. The unusual phi/psi
values are the consequence of these residues being part of
a hairpin type II structure. In VP39, the fourth residue in
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Table 3
Methyltransferase residues involved in interactions with AdoMet/AdoHcy.
Binding-site feature CheR COMT* HhaI† HaeIII‡ TaqI§ VP39#
Hydrogen bonds
with AdoHcy atoms¶
N6; Ade O; Asn212 O; Gln120 O; Asp60 O; Asp50 O; Asp89 O; Val116, m
N6; Ade O; Ala38, m O; Ser119 – – – –
N; HomoCys O; Ala123, m O; Gly66, m – – – O; Gly68, m
N; HomoCys O; Glu129 O; Asp141 – – O; Glu45 O; Asp138
N; HomoCys O; Arg230, m O; Ser72 – – – O; Tyr66
O1; HomoCys – – N; Gly23, m N: Gly12, m – –
O1; HomoCys – – O; Ser305 – O; Glu22 –
O2; HomoCys O; Thr94 O; Ser72 O; Ser305 – O; Thr23 N; Gln39
O2; HomoCys N; Arg98 N; Val42, m N; Leu21, m N; Ala10, m – N; Gly72, m
O2; Ribose O1; Asp154 O1; Glu90 O1; Asp40 O1; Glu29 O1; Glu71 O1; Asp95
O3; Ribose O2; Asp154 O2; Glu90 O1; Asp40 O1; Glu29 O2; Glu71 O2; Asp95
Hydrophobic interactions
with adenine ring
Ile155 Met91 Phe18 Phe7 Ile72 Ile67
Leu213 His142 Trp41 Tyr30 Phe90 Phe115
Val232 Trp143 Ile61 Ile51 Pro107 Val116
Phe236 Pro80 Pro70 Phe146 Val139
Residues in b1/aA loop†† AAASTGE LGAYCGY LFAGLGG LFSGAGG PACAHGP IGSAPGT
*Catechol-O-methyltransferase. †HhaI cytosine methyltransferase.
‡HaeIII cytosine methyltransferase. §TaqI adenine methyltransferase.
#VP39 vaccinia protein RNA methyltransferase. ¶Format: methyl-
transferase atom; residue with m indicating a mainchain atom. ††Bold
residues belong to the loop, the first and the last residues flanking the
loop correspond to the end of b1 and the beginning of aA,
respectively; this region corresponds to the FGLGG sequence in
alcohol dehydrogenase.
the loop is cis proline; this changes the hydrogen-bonding
scheme of the loop and introduces a small displacement in
the aA helix, not observed in the other methyltransferases.
However, the overall shape of the b1/aA loop in VP39 is
still highly similar to all other methyltransferase structures.
Despite the highly similar topologies of methyltransferases
and NAD-binding enzymes, the b1/aA loops, which are of
great importance for both classes of enzymes, exhibit very
different conformations. We have examined this region in
all available structures containing nucleotides in Rossmann-
type a/b folds. The majority of structures contain a b1/aA
loop that is three residues long, similar to alcohol dehydro-
genase; a smaller number of structures contain a loop that
is four residues long, similar to that found in cholesterol
dehydrogenases. Within each of the groups represented by
alcohol dehydrogenase and cholesterol dehydrogenases,
the backbone atoms of the 16 residues that form the b1-
loop-aA region overlay very closely with rms deviations
ranging from 0.33Å to 0.86Å and 0.67Å to 1.03Å, respec-
tively. In the structure of enoyl acyl carrier protein reduc-
tase, although the loop is six residues long, the b strand and
a helix overlay well with the other enzymes (rms deviation
0.67Å). Structural alignment of the b1-loop-aA region of
CheR (residues 118–134) with corresponding residues of
the other methyltransferase structures gives backbone rms
deviation values from 0.69Å for CheR and catechol methyl-
transferase to 1.06Å for CheR and TaqI methyltransferase.
Figure 5 shows the a-carbon models of these loops from the
methyltransferases and the loop region of the alcohol dehy-
drogenase structure, aligned by superimposing the b1
strand and the first two loop residues of the corresponding
structure of CheR. The larger loop found in the methyl-
transferases creates a proper space for binding of AdoMet
and, within the cleft, the a-amino and a-carboxyl groups of
methionine form hydrogen bonds with whatever protein
atoms are available within the appropriate distances. The
loop itself, in different methyltransferases, not only dictates
the shape of the binding cleft, but actually provides the
specific backbone atoms involved in hydrogen-bond forma-
tion with the cofactor or it specifically positions the
sidechains at the end of b1 or at the beginning of aA for
formation of hydrogen bonds (Table 3). Even though there
is sequence conservation within the DNA methyltrans-
ferases, the comparison of diverse and unrelated methyl-
transferases reveals that it is not exclusively the specific
sequence, but rather the specific length and conformation
of the b1/aA loop that allows for AdoMet to bind. In most
of the methyltransferases, the presence of a second domain
also contributes to formation of the binding cleft and the
overall binding energy of AdoMet.
It is now possible to examine the previously identified
regions of primary sequence similarity [32], with respect to
the three-dimensional structures of the methyltransferases.
Two sequences, designated consensus regions II and III, are
located at the beginnings of b strands four and five, respec-
tively, and are distant from the AdoMet-binding site. Exam-
inations of a larger number of methyltransferase sequences
now suggests that these regions are much less conserved
than indicated by the original alignment. The residues that
are fairly conserved (aspartate from region II and lysine/argi-
nine from loop region III) sometimes, but not always, form a
salt bridge. The aspartate residue is also present in a large
number of dehydrogenases. Another sequence, designated
consensus region I, was identified primarily among DNA
methyltransferases. The residues in region I are involved in
formation of the specific b1/aA loop, discussed above. As we
have already concluded, even in methyltransferases in which
the specific consensus region I sequence is not present, the
length and conformation of the loop are conserved. It is
most likely that the consensus region I sequence reflects a
common origin of these enzymes rather than a necessary
requirement for AdoMet binding.
Comparison with CheR homologs from other organisms
The nucleotide sequences of a number of methyltrans-
ferase genes displaying sequence similarity with CheR have
been determined from a diverse array of bacterial species.
An alignment of the predicted amino acid sequences
together with the secondary structure of S. typhimurium
CheR is shown in Figure 6. Overall the sequences exhibit
significant similarity, with identity to S. typhimurium CheR
ranging from 87% for the closely related CheR methyltrans-
ferase from Escherichia coli to 25% for a hypothetical protein
from Campylobacter jejuni. Several features are apparent from
the alignment. Sequence similarity among the large C-ter-
minal domains is much stronger than in the small N-termi-
nal domain. The region comprising the N-terminal domain
differs in length in proteins from different organisms. In
some proteins, the sequence extends beyond the C termi-
nus of S. typhimurium CheR. As might be expected, there
are variations in the lengths of regions corresponding to a
few of the surface loops. Notably, there is weak similarity
in the region of sequence corresponding to the antipar-
allel b-sheet subdomain of S. typhimurium CheR (residues
167–200). However, as was discussed previously in relation
to AdoHcy binding, the residues that are involved in
forming hydrogen bonds to AdoMet/AdoHcy are strictly
conserved, and residues that form the hydrophobic pocket
for the adenine moiety of the cofactor have conserved
aliphatic sidechains. 
The biological and structural implications of the sequence
comparison is that the overall fold, domain structure and
mode of cofactor binding are conserved among these
methyltransferases. With the exception of the proteins
from Rhodobacter capsulatus, C. jejuni and Pseudomonas fluo-
rescens, the proteins presented in Figure 6 have been shown
to be associated with chemotaxis or other motility systems,
and are presumably involved in modification of receptors or
receptor homologs. The substantial divergence in some
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regions of the methyltransferase sequences may allow for
recognition of specific receptors. In different organisms,
chemotaxis receptors exhibit significant variability thus the
specific sequences of the methylation enzymes might allow
them to adopt conformations necessary to recognize unique
features of their substrates. The lower levels of sequence
conservation in the N-terminal domain and in the antipar-
allel b-sheet subdomain of the C-terminal domain are con-
sistent with the hypothesis that these regions may be
involved in interactions with the chemoreceptors. 
Interaction between the methyltransferase and its receptor
substrate
CheR catalyzes the carboxyl methylation of specific glu-
tamyl sidechains within the cytoplasmic domains of
the chemotaxis transmembrane receptors of enteric bacte-
ria, such as E. coli and S. typhimurium. The substrates of
CheR are somewhat diverse — it recognizes four to five -
different glutamyl residues within each of at least five -
different receptors. Comparison of these sites has revealed
a methylation consensus sequence, Glu–Glu–X–X–Ala–
Ser/Thr, with methylation occurring at the second glutamyl
residue [36–39]. Although there is a significant amount of
sequence similarity, and presumably structural homology,
at the different methylation sites [40,38,41], there must also
be differences as reflected by the different rates of methy-
lation observed at each site [21,22,42]. 
In the methyltransferase–substrate (inhibitor) complexes,
for which structures have been determined, the smaller
domain of the methyltransferase is involved in binding the
substrate and positioning it appropriately for presentation
of the substrate methylation site to the methyltransferase
active site located in the large a/b domain. In the HhaI and
HaeIII methyltransferases, DNA binds in a cleft formed
between the small and large domains [35,3], whereas the
catechol O-methyltransferase binds the relatively small
inhibitor 3,5-dinitrocatechol in a shallow groove of the
large domain with hydrophobic interactions contributed by
a residue from a loop of the small domain [5]. Despite the
common participation in binding substrate, the folds of the
small domains of these enzymes are quite distinct. By
analogy with these methyltransferases, the N-terminal
domain of CheR may participate in interactions with
regions of the receptors that contain the methylation sites. 
The methyltransferase CheR binds tightly to the cyto-
plasmic domains of the chemotaxis receptors [43,44]. The
binding site has recently been localized to a five amino
acid sequence, Asn–Trp–Glu–Thr–Phe, located at the
extreme C termini of the E. coli and S. typhimurium aspar-
tate receptors (Tar) and the E. coli serine receptor (Tsr).
The intact receptor and a synthetic pentapeptide of the
binding site motif exhibit similar binding affinities
(Ka ≈4×105 M–1) [23]. On the basis of this observation and
the lack of conservation of this binding motif within all
of the methylated receptors, a model for intermolecular
receptor methylation has been proposed. In this model,
CheR is tethered to the C-terminal tail of one receptor
dimer, from where it methylates an adjacent, and perhaps
heterologous, receptor dimer in the membrane. Although
at this time we have no knowledge of the receptor peptide
binding site in the methyltransferase, the antiparallel
b sheet insertion in the large a/b domain provides an
intriguing candidate. This subdomain, appears to be less
ordered than the rest of the molecule, with average back-
bone atoms B values of 28 Å2 (residues 170–195) as com-
pared to 20Å2 for the rest of the a/b domain. The
b subdomain does not appear to be an integral part of the
overall fold, and has only minimal interactions with the
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Figure 5
Comparison of the cofactor-binding loops of
the methyltransferases and alcohol
dehydrogenase. A stereo view of a-carbon
traces of the b1/aA cofactor-binding loops
from six different methyltransferase crystal
structures (CheR residues 119—134, yellow;
catechol-O-methyltransferase, peach; HhaI
DNA methyltransferase, dark blue; HaeIII DNA
methyltransferase, magenta; TaqI DNA
methyltransferase, green; and RNA
methyltransferase VP39, gray), and alcohol
dehydrogenase (light blue) are superimposed.
The structure of the AdoHcy molecule from
the complex with CheR is also shown as a
ball-and-stick model, with the colors: yellow
for carbon, blue for nitrogen, red for oxygen
and green for sulphur. The figure was
prepared using RIBBONS.
large domain (see Fig. 2 and description of protein archi-
tecture). Nor can the presence of this subdomain be ratio-
nalized in terms of catalysis at the active site, as it makes
no contacts to the bound cofactor. 
We have recently obtained co-crystals of CheR in complex
with the N-acetylated receptor pentapeptide (SD, unpub-
lished results). Notably, crystals of the complex cannot be
obtained under conditions used to grow crystals of CheR
alone. Furthermore, crystals of the complex have a differ-
ent morphology and cell constants than those of CheR,
suggesting perhaps that the peptide influences either the
conformation of CheR or specific lattice contacts between
methyltransferase molecules. The solution of the struc-
ture of the CheR–receptor-peptide complex should eluci-
date the peptide-binding site on CheR and provide a
foundation for further investigations of methyltransferase–
receptor interactions.
Catalytic mechanism
Biochemical analyses of the E. coli and S. typhimurium
methylation systems have indicated that the methylation
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Figure 6
Sequence alignment of CheR homologs from
different organisms. The secondary structural
elements of S. typhimurium CheR are shown
as arrows (b strands), bars (a helices) and
lines (connecting loops) aligned above the
amino acid sequences. Sites where identical
amino acid residues occur in 75% or more of
the proteins are boxed. Residues forming the
linker are labeled with stars. Arginine residues
from helix a2, which are postulated to interact
with the chemotaxis receptors in E. coli and
S. typhimurium, are underlined. Vertical
arrows indicate residues that form hydrogen
bonds with AdoHcy. Accession numbers for
the sequences are: Salmonella typhimurium
(SP, P07801); Escherichia coli (SP, P07364);
Pseudomonas fluorescens (GB, L29642);
Rhodobacter capsulatus (SP, Q02998);
Bacillus subtilis (GB, M80245); Myxococcus
xanthus (SP, P31759); Rhizobium meliloti
(GB, U13166); Rhodobacter sphaeroides
(PIR, S47261); Vibrio anguillarum
(GB, U36378); Pseudomonas aeruginosa
(GB, U11382); Campylobacter jejuni
(SP, P45676); Rhodospirillum centenum
(GB, U64519); and Aerobacter aerogenes
(SP, P21824). SP = SWISSPROT; GB =
GenBank. The program PILEUP from the
Genetics Computer Group Wisconsin
package version 8 was used for the
alignments [58].
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S.typh.    .....MTSSL PSGQTSVLLQ MTQRLALSDA HFRRICQLIY QRAGIVLADH KRDMVYNRLV RRLRALGLDD
E.coli     .....MTSSL PCGQTSLLLQ MTERLALSDA HFRRISQLIY QRAGIVLADH KRDMVYNRLV RRLRSLGLTD
P.fluo.    .......... .......... .......... ......MLLR TGTGHDFKHY KRATVLRRIE RPLQVTAQPD
R.caps.    ..ERPDGATG VAVDDDRVAV GQFDGLEPAE ALGRIVEILS LSGEVNFLDY KPGTVQRRIE RRMGVRQVPD
B.subt.    .......... .......... ........MD TYSVFTTKWK QLTGVDLTLY KEAQMKRRLT SLYEKKGFQS
M.xant.    .......... .......... ...MLTASQK VLQQLAALLL ERAGLKITPD GFHSLRLALS ARMPVLGLEE
R.meli.    ...MRVQANI DQRPYPDECL ASGEYPLTRR DLTEIAAMIY ADAGIYLNES KASLVYSRLS KHIRNLGLKG
R.spha.    .........M KYWS.RQPPT AVRDPQLSQE DFQRIAQLAH AEAGLTMPDA KEPLVYARLA KRLRQLSLTS
V.angu.    .......... .......... .MTAITISDQ EYRDFSRFLE SQCGIVLGDS KQYLVRSRLS PLVAKFKLTS
P.auru.    .......... ..MQANGVWS LQPLADMSAA EFRDWQVLLE NRTGVVLNEQ RRTFLQASLT ARMRELGIGD
C.jeju.    .......... .......... MEKKITPSEL ELNEFIKIIN EMSGIDLTD. KKNILALKLN KFLEGTNTKN
R.cent.    .......... .......... ......MKVE DFDMFCTLLK QRSGLVLTKD KAYLLESRLM PIARKWSVKG
A.aero.    ..MKQDDINA ARESGSAVAQ MAQRLPLSDA HFRRISQLIY QRAGIVLAPH KREMVYNRLV RRLRLLGIHD
           
S.typh.    FGRYLSML.E ANQNSAEWQA FINALTTNLT AFFREAHHFP ILAEH..... ..A....RRR HGEYRVWSAA
E.coli     FGHYLNLL.E SNQHSGEWQA FINSLTTNLT AFFREAHHFP LLADH..... ..A....RRG SGEYRVWSAA
P.fluo.    LAAYHDYL.Q ..MHPEETKA LLGDMLIGVT NFFRDREAFE ALERNVIPAL VKSLQDSQPH REDVRIWSAG
R.caps.    LTSYLELL.T ..HDRTELAS LRREMLIPVT SFFRDPDSFA ELAEKVIDPL VAQAAVG... .STLRVWTAG
B.subt.    FKDFAAAL.E ..KDQALLNE TLDRMTINVS EFYRNYKRWE VLETAILPLI KTS....... .RPLKIWSAA
M.xant.    PEHYIQRL.T GAGGEEELRS LLPLVTVGHT EFFRDAKQFR ALEKSVLPDL VSR...SRRE MRKVSIWSAG
R.meli.    FRDYCQLV.A SPAGAAARRD MLSHLTTNFT RFFRENHHFE HLKTDVLPGL IAR....AKN GGRVRIWSAA
R.spha.    FTAYLDLI.S TPEGRDERSM FISSMTTNTT RFFREEHHFE LLSERVLPPL LDA....ARH GARVRFWSAG
V.angu.    LSDLLRDV.V TGRNRELRVA AVDAMTTNET LWFRDAYPFT VLAERLLPEV AAN....KR. ..PIKIWSAA
P.auru.    YHSYYRQVTD GPRGAVEWAT LLDRLTVQET RFFRHPPSFE LL.ERYLGER LRR....EGM PRPWALWSVG
C.jeju.    FSEFLGKLKS ...NRQLKQE TLDFVTIGET YFLRE..... ......LAQL KEIIYYAKSL EKRVNILSAP
R.cent.    LDELAAMIRT .RKDEALLRD ITEAMTTNES SFFRDQKPFD LFKSVVLPLQ MPS....RQA KKSIRIWSAA
A.aero.    FGDYLALL.E SDPHSAEWQA FINALTTNLT AFF....... .......... .......... ..........
           
S.typh.    ASTGEEPYSI AITLADALGM APG...RWKV FASDIDTEVL EKARSGIYRL SEL.KTLSPQ QLQRYFMRGT
E.coli     ASTGEEPYSI AMTLADTLGT APG...RWKV FASDIDTEVL EKARSGIYRH EEL.KNLTPQ QLQRYFMRGT
P.fluo.    CSTGEEAYSL AIVASEQMAL E.ACNAKLQV FATDIDDRAI AQGRKGVYPE AIV.TDVPPQ RMRQYF...S
R.caps.    CATGEEAYTL AMLFFDAFER A.GRWPTLKI FATDVEPMNI ETAAAGFFAE TIA.ADLPTT FLERFF...T
B.subt.    CSTGEEPYTL AMLLDQQKGL P.G....YQI LATDIDEKAL EKAKKGVYQE RSL.QEVPLS MKDRYF...T
M.xant.    CATGEEPYSL AMVLAE...L G.ALSLEVDL WATDLNLAAV EAAKQGRFTS RRA.ISINQA RLTRFF....
R.meli.    CSDGQEPYSI ALTVLSLLPN AADY..DFRI LATDIDPKIL ALARAGAYDA TAL.ETVNPA MRKQWFSEVE
R.spha.    CSSGEEPFSM AITLLELCPD AGHY..DIKI LATDIDRKIL GRAQAGWFAA SSL.AALPDA VLAHHFGPPD
V.angu.    SSSGQEPYSM AMTVLETQQR KPGMLPSVAI TATDISASML DMCKAGIYDN LALGRGLSPE RRKIFF...E
P.auru.    CSSGEEPYSL AMCAAQVL.R GQEREDFFGV TGTDISLHAL QRARQANYPA RKL.EQLEAG LVERY...CE
C.jeju.    CSSGEEVYSL ALLAAQ.... ..NFIKDMYI LGVDINSSVI EKAKLGKYQG RTL.QRLSES EKRRFFLESE
R.cent.    CSSGQEAYSL LMTLNDEG.H .KVAGWKFDI VGTDISAEMV AKAKAGLYTQ FEV.QRGLPI THLVKYFKQV
A.aero.    .......... .......... .......... .......... .......... .......... ..........
           
S.typh.    GPHEGLVRVR QELANYVEFS SVNLLEKQYN ..VPGPFDAI FCRNVMIYFD KTTQEDILRR FVPLLKPDGL
E.coli     GPHEGLVRVR QELANYVDFA PLNLLAKQYT ..VPGPFDAI FCRNVMIYFD QTTQQEILRR FVPLLKPDGL
P.fluo.    RENQH.YRVR KEIREKVLFA KHSL....LA DPPFSQIDLI VCRNLLIYLD RDVQREILQM FHFALRPGGY
R.caps.    TRGGQ.YTIR PEIRQTIVFA RHNL....LS DPPFTRMDLV TCRNTLIYFR PEAQERALRR MHYAVRTGGY
B.subt.    QNANRSYEVK TEIKKNITFK KHNL....LA DRYEQDFDLI VCRNVFIYFT ESAKEELYLK MAHSLKKNGV
M.xant.    KPVEEGYEAL PALREYIRFD GQNLAVPVFD KVALSSLDLI LCRNVIIYFD LPTIRGLMDR FLAALRPGGL
R.meli.    AGGRRKWQVD DRVKRLITFN ELNLM.AQWP ..IKGPFDVI FCRNVVIYFD EPTQMKIWSR FAGVLDNGGH
R.spha.    RDGRR..EVS ADLRALVTFK PLNLV.KPWP ..VTRPFDVI FCRNVAIYFD PDTQNRIWRG FASTLAPGGH
V.angu.    DAGDGRMKIK DNVKRLVNFR PQNLMES.YA ..LLGKFDII FCRNVLIYFS PDMKSKVLNQ MASSLNPGGY
P.auru.    RQADGSFSVK TILTERVCCA RLNVLDLAKA ..PWSGMDVI FCQNLLIYFR RWRRREILNR LAERLAPGGL
C.jeju.    ...DKFYTIN KNELCTCKFE LCNVFEEKFS R..LGKFDII ASRNMIIYFD HESKLKLMER FHRILNDKGR
R.cent.    ..GDKW.QIS DDLRSRVQFR EYNLLSD.LS ..PLGQFDVI FCRNVLIYFD QPTKTKVLEA MARMLPPDGV
A.aero.    .......... .......... .......... .......... .......... .......... ..........
           
S.typh.    LFAGHSENFS NLVRE.FSLR GQTVYALSKD KA........ ........
E.coli     LFAGHSENFS HLERR.FTLR GQTVYALSKD .......... ........
P.fluo.    LFLGSSESAD GCQDLFVPVD KRNRIFR.VR PNSA..TVRR APTM....
R.caps.    LFLGGSEALV QVQDDFSVLS ARHRIWQALR PGAAPLTDRR A.......
B.subt.    LFVGSTEQIF N.PEKFGLVP ADTFFYQKKI D......... ........
M.xant.    LFLGYSESLF KVYDRFEMIE VDGAFVYRRP LNDKSMRAPP LR......
R.meli.    LYIGHSERVS GDAKALFDNI GITTYRHTGK FHGGRA.... ........
R.spha.    LFIGHSERLS HEVRHQFETV GMTSFRLRAP PPTGGPGKEI FGGTQGQH
V.angu.    LLLGASESLT GLTDKFEMVR CNPGIIYKLK .......... ........
P.auru.    LVIGVGEVVD WSHPELEPVA DERVLAFTRK GYSGT..... ........
C.jeju.    LYVGNAD.LI PETIYFKKIS LQEVFTMKKY KF........ ........ 
R.cent.    LYLGGAETVL GITDKFKPME GQRGLYQLAS APAPKIG
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reaction catalyzed by CheR proceeds by a random
mechanism [28]. The turnover number of 10min–1 and the
absence of a covalent enzyme–substrate intermediate
support a reaction model involving direct transfer of a
methyl group from AdoMet to the glutamyl carboxyl of a
specific sidechain of a chemotaxis receptor. It is also
known that direct methyl transfer reactions occur by an
SN2 type of mechanism [45], thus the reaction rates are
strongly dependent on characteristics of the nucleophile,
in this case, the receptor glutamate carboxylate oxygen.
The active site for methyl transfer necessarily involves
residues from both the region of the receptor that is
methylated and CheR. On the basis of the knowledge of
the reaction mechanism and insights provided by the
structure of the CheR-AdoHcy complex, we propose the
following: firstly, binding of the methylation region of the
chemotaxis receptor occurs within the wide opening of
CheR, formed by the central AdoMet-binding site,
flanked on either side by the b subdomain and the N-ter-
minal helical domain; secondly, formation of the Michaelis
complex follows a conformational change in CheR and
possibly in the substrate as well; and thirdly, reaction rates
are dependent on the specific presentation of the receptor
glutamate residues to the interaction surface of CheR,
which probably involves the positively charged helix a2. 
In the structure of the CheR–AdoHcy complex, the cofac-
tor is fully buried in the protein-binding cleft with no
atoms accessible to solvent. The inclusion of a methyl
group at the sulfur atom of homocysteine, which would
correspond to a molecule of AdoMet, might require some
movement of the surrounding sidechains, such as Tyr235
or even Arg89. Binding of the receptor substrate could
entail additional conformational changes, necessary to
properly position and orientate the reactive groups. Such
movement has previously been observed in the complex
of DNA–HhaI DNA methyltransferase, in which binding
of DNA to the enzyme was associated with a significant
conformational change within the DNA-binding domain
as well as distortion of the DNA helix, with the methylat-
able base completely flipping out from the helix [35]. The
intramolecular surface of interaction between N-terminal
and C-terminal domains of CheR is relatively small (about
400Å2) and is primarily built of several hydrogen bonds
and a few hydrophobic interactions. These domains could
potentially move in some type of the hinge motion,
forming a complex with the receptor substrate or perhaps
opening the active site to allow for binding of AdoMet. 
The observed differences in rates of carboxyl methylation
reactions at different glutamate residues can be explained
by two different effects, or perhaps by a combination of
both. One possibility is that the reaction rates are deter-
mined by the strengths of the nucleophile — carboxyl
oxygen or by the mobility of a leaving methyl group,
both of which can differ depending on other factors. This
would suggest the involvement of an additional residue
that would specifically stabilize a transition state. For
example, an oxygen of a glutamate or tyrosine residue
might interact with the positively charged sulfur atom, as is
postulated in the reaction mechanism of glycine methyl-
transferase, or some positively charged residue might inter-
act with the glutamyl substrate (analogous to the role of
Mg2+ in catechol methyltransferase). The presence of a
receptor methylation consensus sequence Glu–Glu*–X–X–
Ala–Ser/Thr (X=any residue; Glu*=methylated residue)
implies, however, that the active-site residues contributed
by both CheR and the receptor are similar for all four
methylatable glutamate residues. Hence, it is more likely
that the reaction rates are determined by another mecha-
nism, such as the availability, specific orientation and posi-
tioning of the glutamate residues for methylation, rather
than by a different composition of active-site residues.
This interpretation is also supported by the mutagen-
esis studies of Shapiro and Koshland, which have shown
that the shorter carboxylate sidechain of aspartates cannot
be methylated and that substitution of a methylatable
glutamate with aspartate drastically decreases the rate of
methylation on the glutamate residue N-terminal to the
mutation [21].
Calculated electrostatic potentials (GRASP) [46] of the
CheR surface revealed that the proposed surface area of
interaction with the receptor is positively charged overall.
This region includes an approximately 12 Å wide posi-
tively charged surface, leading to the AdoHcy-binding
pocket (Fig. 7). Charges in this area are provided by helix
a2; three arginine residues (53, 56 and 59) are lined up on
one face of the helix and are oriented towards the pro-
posed receptor interaction opening. Methylatable gluta-
mate residues on the receptor are followed by two to three
non-methylatable glutamates in the first a helix and pre-
ceded by four to five non-methylatable glutamates in the
second a helix of the predicted antiparallel coiled coil of
the receptor cytoplasmic domain [41]. It is possible that
these residues, all of them seven residues apart, form a
negatively charged surface that is involved in specific
interactions with the positively charged surface of CheR
and that this complementary electrostatic interaction
serves to position the methylatable glutamates within the
active site. 
It should be noted that helix a2 is significantly distorted,
due to the hydrogen bonds formed by sidechain atoms
of its residues and the mainchain atoms of the same or
neighboring molecule (lattice contacts). This observation
suggests a flexibility of this helix and its potential for
adopting slightly different conformations that might be
necessary for interaction with the receptor. 
According to the model of Wu et al. [23], the recep-
tor substrate, via its C-terminal pentapeptide, will bind
Research Article  Chemotaxis receptor methyltransferase Djordjevic and Stock    555
CheR at an independent site (perhaps involving the
CheR b subdomain) and from that tethering point allow
for the dynamic interaction of different receptor gluta-
mate residues with the AdoMet bound to CheR. Differ-
ent positions of the substrate glutamates on the helix of
the predicted coiled coil might place particular residues
in a more favorable position for methyl transfer than
others, even though all contain a common consensus
sequence for interaction with CheR. This scenario does
not eliminate the potential role for specific CheR or
receptor residues in stabilization of a transition state.
However, a detailed description of the complete active
site and reaction mechanism will only be possible with
a combination of structural information for the recep-
tor–CheR complex and further mutagenesis data.
Biological implications
Bacterial chemotaxis receptors are transmembrane pro-
teins that detect environmental stimulants through their
periplasmic domains and transduce the signal to proteins
downstream of the cytoplasmic two-component signaling
system. In addition to the effect of ligand binding, the sig-
naling output of the chemotaxis receptors is modulated
by the level of covalent modification — methylation of
specific glutamate residues on the cytoplasmic domains.
Methylation of the chemotaxis receptors counter-effects
ligand binding. Methylation of the receptor glutamate
carboxylate groups is catalyzed by CheR, a methyltrans-
ferase that uses an S-adenosyl-L-methionine (AdoMet).
CheR belongs to a broad class of AdoMet-dependent
methylating enzymes that are involved in numerous
processes, such as the synthesis of antibiotics, the metab-
olism of neurotransmitters and the covalent modifica-
tion of DNA, RNA, and proteins. Previously, structural
analyses have been carried out on the small molecule,
RNA and DNA methyltransferases. The crystal struc-
ture of CheR, determined at 2.0Å resolution, is the first
structure of a protein methyltransferase.
Protein methylation occurs at amino groups, where
it is irreversible and presumably has a structural role,
or at carboxyl groups where it is reversible and is
postulated to be involved in protein repair and signal 
transduction. CheR is a two-domain protein carboxyl-
methylating enzyme. The basic structural elements
of the polypeptide topology of the larger a/b C-terminal
domain of CheR are similar to those of DNA methyl-
transferases, an RNA methyltransferase, and catechol-
O-methyltransferase. The unusual topological features
of CheR are its helical N-terminal domain and the pres-
ence of a small three-stranded antiparallel b subdomain
inserted within the C-terminal domain.
The CheR structure allows for a comprehensive
comparison of AdoMet-binding sites among DNA,
RNA, small molecule and protein methyltransferases.
Although there is little conservation of amino acid
sequence motifs, the AdoMet-binding sites are struc-
turally conserved. The specific length and conformation
of a loop within the a/b domain (the b1/aA loop in
CheR), rather than a specific sequence, are implicated
in providing the specificities for AdoMet binding by
methyltransferases. The unique structural elements of
CheR — specifically, the antiparallel b subdomain and
N-terminal domain of the methyltransferase — are
probably involved in both tethering the methyltrans-
ferase to the receptor and in the interaction with the
receptor methylation region. The structure of CheR lays
the foundation for detailed examination of the interac-
tions between a modification enzyme and its multiple
chemotaxis receptor substrates.
Materials and methods
Crystallization
Crystals of S. typhimurium CheR were obtained as previously described
[47]. The crystals were prepared using the hanging drop method with
a reservoir solution of 1.2 M ammonium sulfate, 2% PEG 400, 25mM
sodium citrate, pH 5.6. For the purpose of introducing heavy atoms,
native crystals were transferred to a solution containing 1.4 M ammo-
nium sulfate, 2% PEG, 25 mM sodium citrate, pH 7.0. Subsequently, the
crystals were transferred to drops that additionally contained appropri-
ate concentrations of heavy metals.
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Figure 7
Calculated electrostatic potential surface of the CheR–AdoHcy
complex. Electrostatic potential on the molecular surface of CheR is
color coded as red for negatively charged, blue for positively charged
and gray for neutral regions. An arrow points to the position of the
sulfur atom in AdoHcy that is not solvent exposed. The figure was
generated using GRASP [46].
Data collection 
The crystals belong to the monoclinic space group P21, with cell dimen-
sions a = 55.0 Å, b = 48.0 Å, c = 63.2 Å and b= 112.3°. There is one
CheR molecule in the asymmetric unit and the solvent content is 40%.
All data sets were collected at room temperature on an R-Axis II
(Rigaku) image plate detection system mounted on a Rigaku rotating
anode generator operated at 50 mA and 100 kV, with double mirror
focusing (Molecular Structure Corporation). Data were integrated using
the program Denzo [48]. All data were merged, scaled and truncated
with the Rotavata/Agrovata and Truncate programs in the CCP4 suite
[49]. Potential heavy-atom derivative data were scaled to the native
data set using the program Scaleit in CCP4.
MIR phasing, model building and refinement
Difference Patterson maps, calculated with derivative and native pH 5.6
data, were generated and examined using the programs Topdel, Fsfour
and Mapview from the PHASES program suite [50]. Coefficients for a
cross-difference Fourier synthesis were calculated with the program
Mrgdf (PHASES). Heavy-atom sites were identified by examination of
difference Patterson maps, and subsequently validated by cross-differ-
ence analysis.
We were able to obtain only mercury and K2PtCl4 derivatives, despite
an extensive search through a variety of compounds. All of the mercury
derivatives had two major and mainly overlapping sites, which in the
final model could be correlated with the positions of Cys31 and
Cys229. Combination of all mercury derivatives and solvent flattening
of the resulting phases yielded a poor electron-density map that, apart
from detectable features for two a helices, was not interpretable. Plat-
inum atoms from K2PtCl4 bound very strongly to CheR crystals with
the main site at 0.0, 0.25, 0.45 (relative to the main Hge specific posi-
tions of the Pt atoms, Pt-derived phases were pseudo-centrosymmet-
ric and when used in the cross-difference Fourier method they gave
an ambiguous solution in the Y direction for the mercury positions,
even though the X and Z coordinates of the mercury atoms were
confirmed. An interpretable electron-density map was obtained with
phases derived by combination of all of the derivatives followed by
density modification procedures.
The positions and occupancies of the heavy atoms for each of the
derivatives were refined individually in MLPHARE (CCP4) [51] and
then combined, giving a figure of merit of 0.71. The handedness of the
structure was determined using anomalous data for one of the mercury
derivatives. MIR phases were calculated for data between 35.0 and
3.0 Å resolution. These phases were subjected to density modification
using the program DM (CCP4) [52], which included solvent flattening,
histogram matching and Sayer’s equation options. Exclusion of any of
the mercury derivatives resulted in much poorer quality of the phases.
MIR/DM phases were used to calculate electron-density maps with
data from 25–4 Å and 25–3 Å. A number of a helices and b strands
were clearly identified. Both maps were used for the initial Ca-chain
tracing, aided by the bones option within the graphics program Turbo-
Frodo [53]. Turbo was used for all of the map interpretation, model
building and subsequent map fittings. There was several regions of
ambiguity within the maps. Great improvement in the quality of the
electron-density map was achieved by using the iterative skeletoniza-
tion process implemented in DM. At this time, the phases were
extended to 2.7 Å. The resulting electron-density map enabled us to
trace 243 out of 287 residues. Residues 1—11 and 285—287 were
missing, and the region between residues 166 and 200 fell within dis-
ordered electron density that was difficult to interpret. The partial model
was taken through several rounds of positional and simulated-annealing
refinement in X-PLOR [54], followed by refitting of the electron-density
maps. Model rebuilding was done by examining SIGMAA weighted
maps, and 3Fo–2Fc and original MIR/DM electron-density maps. In the
first few cycles, refinement was carried out with data from 8—3.0 Å,
after which the resolution was extended to 2.4 Å. Calculated phases
from the improved model revealed better features in a 3Fo–2Fc elec-
tron-density map, such that it was possible to trace residues 167—199
and confirm sidechain assignments. The new model, which included
residues 11—284 as well as AdoHcy, was refined in X-PLOR starting
with 2.4 Å and then including data to 2.0 Å, resulting in a working factor
of 0.277 and a Free R factor of 0.367, without any water molecules
and B factors included in refinement. This model was then refined
against the native data set at pH 7.0, which has slightly better statistics
and higher completeness compared to the pH 5.6 data set. Water mol-
ecules were added using unrestrained and restrained refinement of
ARP [55]. Water molecules were carefully examined and another round
of X-PLOR refinement was carried out yielding the final model.
Accession numbers
Atomic coordinates have been deposited in the Brookhaven Protein
Data Bank, with the code 1af7. 
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